Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GOP Lawmakers Want Briefing On $1.3Bn Spent On Chinese COVID-19 Tests

Executive Summary

A letter sent by 13 House Committee on Oversight and Reform members to HHS Sec. Xavier Becerra asks for information on purchases of tests made overseas, as well as efforts to develop and manufacture diagnostics for future infectious disease outbreaks within the US.

You may also be interested in...



Abbott Lands $1Bn Contract From DoD To Ramp Up COVID-19 Testing

The Department of Defense has awarded a series of contracts to meet the Biden administration’s pledge to supply the nation with a billion at-home COVID-19 rapid tests.

News We’re Watching: CDRH’s Maisel Announces Retirement, Fresenius Clearance, Philips and Smiths Recalls

This week, a device center stalwart prepared to say goodbye; the FDA cleared Fresenius's 5008X Hemodialysis System; and class I recalls for Smiths Medical and Philips Imaging were announced. 

FOIA Claims Bring Electroshock Device Dispute Back To Courts

A year after Congress officially gave the FDA the power to ban devices for a specific use, the school that inspired the new law is taking the agency back to court on allegations it has failed to respond to document requests. 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145966

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel